RFC
RARE icon

Regions Financial Corp’s Ultragenyx Pharmaceutical RARE Stock Holding History

Regions Financial Corp’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11
Closed -$1K – 1512
2019
Q1 		$1K Hold
11
– – ﹤0.01% 1875
2018
Q4 		$0 Hold
11
– – ﹤0.01% 1986
2018
Q3 		$1K Hold
11
– – ﹤0.01% 1916
2018
Q2 		$1K Buy
+11
New +$710 ﹤0.01% 2015

Other funds holding RARE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Regions Financial Corp's RARE Position: Q2 2019 in Review

Regions Financial Corp sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2019, closing a stake of 11 shares — an estimated $1K sold.

Regions Financial Corp first reported a position in RARE in Q2 2018 and held it in 4 quarters. The position peaked at $1K in Q1 2019. 170 funds tracked by Wall St. Rank hold RARE as of Q2 2019.

  • Regions Financial Corp reported no remaining Ultragenyx Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • Regions Financial Corp sold 11 Ultragenyx Pharmaceutical shares in Q2 2019, an estimated $1K.
  • Regions Financial Corp first reported a position in Ultragenyx Pharmaceutical in Q2 2018 and held it in 4 quarters.
  • Regions Financial Corp's Ultragenyx Pharmaceutical position peaked at $1K in Q1 2019.
  • 170 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.